New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 6, 2014
10:01 EDTBIIB, ED, SBLK, NM, IPHI, COG, AXLL, TEVA, YUM, NS, MTRN, HA, BOBE, ALGT, APC, TIF, NTI, KIRK, HEESOn The Fly: Analyst Upgrade Summary
Allegiant Travel (ALGT) upgraded to Outperform from Market Perform at Raymond James... Axiall (AXLL) upgraded to Buy from Neutral at Goldman... Biogen (BIIB) upgraded to Outperform from Market Perform at BMO Capital... Bob Evans (BOBE) upgraded to Buy from Hold at Miller Tabak... Cabot Oil & Gas (COG) upgraded to Buy from Neutral at UBS... H&E Equipment (HEES) upgraded to Buy from Neutral at UBS... Hawaiian Holdings (HA) upgraded to Buy from Hold at Deutsche Bank... Inphi (IPHI) upgraded to Buy from Hold at Jefferies... Kirkland's (KIRK) upgraded to Buy from Hold at KeyBanc... Materion (MTRN) upgraded to Buy from Hold at KeyBanc... Navios Maritime (NM) upgraded to Buy from Hold at Stifel... Northern Tier (NTI) upgraded to Overweight from Equal Weight at Barclays... NuStar Energy (NS) upgraded to Overweight from Neutral at JPMorgan... Star Bulk Carriers (SBLK) upgraded to Buy from Hold at Stifel... Tiffany (TIF) upgraded to Buy from Neutral at Citigroup... Yum! Brands (YUM) upgraded to Outperform from Neutral at RW Baird... Consolidated Edison (ED) upgraded to Buy from Hold at Argus... Anadarko (APC) upgraded to Buy from Hold at Argus... Teva (TEVA) upgraded to Outperform from Market Perform at Leerink.
News For ALGT;AXLL;BIIB;BOBE;COG;HEES;HA;IPHI;KIRK;MTRN;NM;NTI;NS;SBLK;TIF;YUM;ED;APC;TEVA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
December 8, 2014
06:35 EDTSBLKStar Bulk Carriers initiated with a Hold at Deutsche Bank
Subscribe for More Information
December 5, 2014
09:03 EDTBOBEBob Evans says financial statements can be relied upon
Subscribe for More Information
07:54 EDTTEVALannett names Michael Bogda as president, effective December 1
Subscribe for More Information
05:17 EDTALGTAllegiant Travel sees 1Q15 system departures up 3%-7%
Subscribe for More Information
05:15 EDTALGTAllegiant Travel sees Q4 system departures up 11%-13%
Subscribe for More Information
05:12 EDTALGTAllegiant Travel sees Dec. scheduled departures up 4%
Sees December ASMs up 4%.
05:11 EDTALGTAllegiant Travel reports Nov. scheduled service passengers up 13% to 616,038
Subscribe for More Information
December 4, 2014
10:32 EDTTEVATeva receives positive outcomes in Europe for three-times-a-week COPAXONE
Teva Pharmaceutical Industries announced that it has received a positive outcome in the decentralized procedure for its new, three-times-a-week COPAXONE 40 mg/ml formulation for the treatment of adults with relapsing forms of multiple sclerosis RMS. The outcome follows a Positive Assessment Report from the United Kingdom, the Reference Member State’s Medicines and Healthcare Products Regulatory Agency, and all Concerned Member States in Europe who were involved in the procedure. Granting of national authorizations will happen in the near future. The three-times-a-week COPAXONE 40 mg/ml formulation will allow for an improved, less-frequent, subcutaneous dosing regimen for adults with RMS. The new formulation reduces the total number of injections by almost 60%, while maintaining the known benefits of once daily COPAXONE 20 mg/ml. “We welcome the opportunity to make COPAXONE 40 mg/ml available to patients with RMS in Europe,” said Rob Koremans, MD, President and CEO of Global Specialty Medicines at Teva. “Three-times-a-week COPAXONE 40 mg/ml will be available in Europe as early as the first quarter of 2015 with expected launches in Germany, Netherlands and Denmark. Launches in other EU countries are expected throughout 2015.”
10:08 EDTNTIOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:49 EDTNTINorthern Tier initiated with a Hold at Tudor Pickering
Subscribe for More Information
05:30 EDTTEVACTI BioPharma receives $15M payment from Teva for TRISENOX
Subscribe for More Information
December 3, 2014
17:05 EDTALGTAllegiant Travel declares special dividend of $2.50 per share
Subscribe for More Information
16:51 EDTBOBEBob Evans says Q1 financial statements should no longer be relied upon
Subscribe for More Information
16:32 EDTMTRNMaterion CFO John Grampa retiring, succeeded by Joseph Kelley
Materion CFO John D. Grampa plans to retire from the company prior to the end of 2015, following 17 years of service with Materion. The board of directors has appointed Joseph P. Kelley to succeed him effective January 1, 2015. Mr. Grampa assumed the CFO role in November 1999. Until his retirement, he will maintain his responsibilities and will continue to work with Mr. Kelley to ensure a smooth transition. Mr. Kelley has served as Vice President, Finance, since October 2013.
10:05 EDTBOBE, TIFHigh option volume stocks
High option volume stocks: BOBE KOG PRTA TIF HLSS KN PBYI TER PWRD SXE
10:00 EDTBOBEOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:35 EDTCOGConstitution Pipeline receives FERC approval to construct project
Subscribe for More Information
07:22 EDTBOBEBob Evans downgraded at KeyBanc
As previously reported, KeyBanc downgraded Bob Evans to Underweight from Hold. The firm downgraded shares following Q2 results citing ongoing structural issues, and lack of shareholder friendly capital options. Price target is $45.
07:05 EDTBIIBBiogen to present data from hematology programs at ASH meeting
Subscribe for More Information
06:23 EDTBOBEBob Evans downgraded to Underweight from Hold at KeyBanc
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use